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Cardiovascular magnetic resonance (CMR) (Table 1), one
of the newest cardiovascular imaging modalities, provides
useful, often unique information with which all cardiologists
should be conversant. Accordingly, cardiovascular trainees
should receive training that would provide at least a basic
understanding of the methods and utility of CMR in the
practice of cardiology. To accomplish such an understand-
ing for fellows with different levels of interest in CMR,
training in CMR should be provided at 3 levels—general,
specialized, and advanced.
Training Levels
Level 1—General training (1 month) should provide the
cardiovascular trainee with a working knowledge of CMR
methods and their diagnostic utility.
Level 2—Specialized training (at least 3 months) de-
signed to provide the trainee in cardiovascular diseases with
the skills necessary to independently interpret CMR imag-
ing studies.
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Level 3—Advanced training is provided for those who
ultimately wish to be responsible for the operation of a
CMR laboratory. Level 3 criteria must include adequate
levels of patient care, teaching, and research.
Overview of CMR Training
All cardiovascular medicine trainees should be taught the
basic types of CMR studies and their indications. Men-
tored interpretation of CMR studies should be coupled
with comparison and integration of results with other
relevant clinical and laboratory testing. A mentor is an
individual with the equivalent of Level 3 CMR training.
This training generally should be acquired through the
Accreditation Council for Graduate Medical Education
(ACGME)—an approved cardiology or radiology pro-
gram with expertise in CMR and under the aegis of a
Level 3-qualified mentor in a laboratory accredited by an
organization such as the Intersocietal Commission on the
Accreditation of MR Laboratories (ICAMRL). Occa-
sionally, a Level 3-qualified mentor will not be available
in the institution housing the general fellowship pro-
gram, but is available at a nearby nonacademic medical
center accredited for CMR by an organization such as the
ICAMRL. Under these circumstances it is acceptable to
provide the training in CMR at such a medical center for
all levels of training. The CMR training center and the
trainee should maintain a logbook or other specific
records to document the cases reviewed and the didactic
hours in which the trainee has participated.
The depth of knowledge should increase with increasing
levels of training. In the case of the Level 3 trainee,
specialized training and, for academic trainees, research
training related to CMR should be offered as a part of an
established training program (Table 2).
Level 1: General Training (1 Month Minimum)
The trainee should have exposure to the methods and the
multiple applications of CMR for a period of not less than
1 month or its equivalent when integrated with other
training activities. This experience should provide basic
background knowledge in CMR sufficient for the practice of
adult cardiology and referral for CMR evaluation, but not
for the practice or independent clinical interpretation of
CMR. As a practical matter, many fellowship programs in
cardiovascular medicine may not be able to fulfill CMR
training. In these instances, fellows should be encouraged to
obtain experience in an alternate program with appropriate
training and accreditation in the performance of CMR
studies.
Classification of CMR Procedures
Table 1 Classification of CMR Procedures
1. Standard CMR procedures, including:
a. Tomographic still-frame CMR for morphology using “bright” and/or “dark blood” methods with and/or without a paramagnetic contrast agent
b. Cine and other approaches to CMR for assessment of ventricular function
c. Magnetic resonance angiography and cine CMR of the great vessels, anomalous coronary arteries, and coronary artery bypass grafts
d. Delayed contrast-enhanced CMR for myocardial infarction, scar, intraventricular thrombus, and microvascular obstruction (associated with myocardial infarction) and
viability assessment and visualization of other causes of abnormal myocardial interstitium
e. First-pass CMR (with vasodilator infusion) or cine CMR with stress (with inotropic agent) for myocardial perfusion evaluation, ischemia detection, and assessment of
patients with coronary microvascular disease
f. Phase-contrast velocity mapping for blood flow quantification for shunt sizing and determination of valvular regurgitation and stenosis
g. Peripheral magnetic resonance angiography
2. Less common procedures, including:
a. Myocardial tagging (approach unique to CMR that allows more detailed evaluation of intramural and transmural myocardial function than ventriculography alone and
for evaluation of pericardial disease)
b. Coronary magnetic resonance imaging of the native coronary arteries
c. Magnetic resonance spectroscopy using 31P (to assess “high energy phosphate metabolism”) or other nuclei
CMR  cardiovascular magnetic resonance.
Components of CMR Training
Table 2 Components of CMR Training
1. Didactic activities
a. Lectures (It will be necessary in learning the physical principles and in case interpretation to derive such information from relevant lectures; no more than 5% of the
cases.)
b. Self-study (it is possible to use cases from teaching files, journals, textbooks, or electronic/on-line courses. Such self-study cases need to be well documented in the
trainee’s records and should not comprise any more than 50% of the cases studied.)
2. Independent interpretation of CMR cases (performed in the mentoring CMR laboratory)
3. Participation in CMR case study interpretation
4. “Hands-on” CMR experience
CMR  cardiovascular magnetic resonance.
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Didactic Activities
Interpretation of CMR studies. During his or her 1
month of training, the trainee should actively participate in
daily CMR study interpretation under the direction of a
Level 2- or Level 3-trained CMR physician-mentor. For all
studies in which angiographic, echocardiographic, radionu-
clide, computed tomographic, or hemodynamic data are
available, this other imaging information should be corre-
lated with CMR studies. Studies should include the range
of procedures listed in Table 1. Experience in interpretation
(a minimum of 25 cases) may include studies from an
established CMR teaching file.
Lectures and self-study in CMR. This component should
consist of lectures on the basic aspects of CMR and parallel
reading material consisting of selected articles, digital train-
ing programs, or CMR text. The lectures and reading
should provide the fellow with an understanding of CMR
applications. Specificity, sensitivity, diagnostic accuracy,
utility in assessing prognosis, costs, artifacts, indications,
contraindications, and pitfalls must be included for each
cardiovascular diagnostic subset. Such information could be
effectively transmitted within a weekly noninvasive or clin-
ical teaching conference during which CMR data are
presented.
A basic understanding of magnetic resonance physics should
be provided, including the following: 1) the physics of mag-
netic resonance as it relates to image intensity and contrast,
including flow, T1, T2, density of nuclear species (e.g.,
proton), and contrast agents; 2) sources of artifacts, including
motion, arrhythmias, and metal objects; 3) safety of implanted
devices (e.g., pacemakers, automatic implantable cardioverter-
defibrillators), external ferromagnetic devices, and gadolinium-
based contrast agents (for a summary of safety issues in CMR,
see www.mrisafety.com); and 4) basic post-processing ap-
proaches and analyses.
Hands-On Experience
Hands-on experience is not necessary for Level 1.
Level 2: Specialized Training
(at Least 3 Months)
Training for Level 2 should include the CMR experience
described for Level 1. Level 2 is for those trainees who
wish to practice the clinical subspecialty of CMR, includ-
ing independent interpretation of CMR studies. Level 2
trainees must have at least 3 months of dedicated CMR
training (where 1 month is defined as 4 weeks and 1 week
is defined as 35 h), including the basic elements listed in
the following text. The trainee would be expected to
become familiar with the CMR techniques listed in
Table 1.
Background
An understanding of CMR physics should be substantially
more advanced than in Level 1 training (see the following
text).
Didactic Activities
Interpretation of CMR studies. During their 3 or more
months of experience, trainees should actively participate in
daily CMR study interpretation under the direction of a
Level 2 or Level 3 (preferred) CMR-qualified physician-
mentor. For all studies in which other cardiac imaging data
are available, such information should be correlated with
CMR data. The trainee should interpret at least 150 CMR
examinations during this training period, including 50 for
which the trainee is present during the scanning procedure,
ideally as the primary operator, and is the primary inter-
preter. Up to 50 of the 100 examinations for which the
trainee is not the primary interpreter can be derived from
established teaching files, journals and/or textbooks, or
electronic/on-line courses. Careful documentation of all
case material and the details of the way in which the case
was derived are essential.
Lectures and self-study in CMR. Course work would
include the components for Level 1 training but should also
include more advanced lectures and reading materials. This
work, with parallel reading, should continue for the dura-
tion of the traineeship. Course work should include the
following:
1. Physics: Trainees should receive didactic lectures from a
CMR-trained physician (who has achieved Level 2 or 3
in CMR) and/or physicist on the basic physics of
magnetic resonance in general and as it relates to CMR
in particular. The content should include the same
materials as in Level 1 (basic) plus lectures with support-
ive reading on the following topics:
a. Image formation, including k-space, gradient echo,
spin echo, fast spin echo, echo planar, spiral, steady
state free precession (SSFP), and parallel imaging
b. Specialized imaging sequences, including flow and
motion, phase imaging, time of flight, contrast
agents, and radiofrequency tagging
c. Hardware components, including the elements of gra-
dient coil design, receiver coils, and digital sampling
2. Applications, interpretation, indications, and contraindi-
cations: Level 2 didactic activities should include an
understanding of the sensitivity, specificity, accuracy,
utility, costs, acquisition approaches, and disadvantages
of all of the contemporary techniques in CMR. The
following techniques should be covered in the didactic
program:
a. Imaging of structure and tissue characterization (T1,
T2, spin echo, gradient echo, SSFP, image contrast
mechanisms, and fat suppression)
b. Imaging of function (cine and tagged cine magnetic
resonance including SSFP imaging approaches)
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c. Volumetric imaging of mass, biventricular volumes,
and ejection fraction (using cine magnetic resonance
imaging)
d. Flow imaging (e.g., velocity-encoded techniques)
e. Imaging of myocardial infarction, scarring, and via-
bility assessment (delayed contrast-enhancement im-
aging)
f. Pharmacologic stress testing with evaluation of ven-
tricular function and/or first-pass perfusion imaging
using a contrast agent
g. Magnetic resonance angiography (vascular)
h. Mechanisms, types, and pharmacologic aspects of
CMR contrast agents
i. Electrocardiogram and peripheral pulse gating and
triggering including timing of image acquisition
within the R-R interval, motion artifacts and their
effects on CMR images; respiratory motion suppres-
sion methods (e.g., breath-holding and navigators)
j. Magnetic resonance spectroscopy methods (e.g.,
depth resolved surface coil spectroscopy, or DRESS,
and 3-dimensional Fourier transform approaches)
k. CMR image analysis and post-processing tools
l. Contraindications for CMR study
m. Incidental findings suggesting pathology outside of
the cardiovascular system
Evaluation
The person responsible for the CMR training program must
be responsible for assessing the competence of the CMR
trainee at the completion of the program. This is accom-
plished by examining the ability of the trainee in the
understanding of the acquisition methods, the interactive
role of the operator during the performance of CMR
studies, and the interpretation of the data acquired during
daily reading sessions. This may be supplemented by formal
didactic training.
Level 3: Advanced Training (at Least 12
Months for Those Interested in Pursuing a
Clinical or Academic Career in CMR or
Directing a CMR Laboratory)
Level 3 CMR training represents the highest level of
training and would enable the cardiovascular trainee to
pursue a clinical or academic career in CMR and to direct a
CMR laboratory. Level 3 training in CMR could be
obtained as part of a 3- or 4-year cardiology fellowship. In
addition to the recommendation for Level 2, the Level 3
academic program should include active participation in an
ongoing basic and/or clinical CMR research, with indepen-
dent responsibility for a specific portion of that research.
Focused research work with publication of 1 or more
manuscripts is an essential component of Level 3 training.
Level 3 training must be performed under the guidance of at
least one Level 3-trained CMR physician.
In parallel with research activities, the Level 3 trainee
must participate in clinical imaging, which should include
supervised interpretation of at least 300 CMR cases. The
trainee must be physically present and involved in the
acquisition and the primary interpretation of at least 100
CMR cases. In the remaining 200 cases, the trainee should
review at least 100 of these cases with the Level 3 mentor.
The remaining cases can be derived from established teach-
ing files, journals and/or textbooks, or electronic/on-line
courses. Careful documentation of all case material and
details of the way in which the case was derived are essential.
Knowledge of magnetic resonance physics must be more
advanced than that included in Level 2 training and include
the following:
1. An understanding of why certain specialized imaging
sequences are applicable for specific clinical protocols,
including imaging of heart function, coronary arteries,
perfusion, delayed enhancement, and peripheral arteries.
2. Basic understanding of the clinically applicable spectro-
scopic methods.
3. The essentials of data collection, including capturing of
digital data, the maintenance of accurate databases and
records, signal processing, and the approaches for quan-
titating data.
Evaluation
Evaluation should be similar to that of Level 2.
Summary of recommendations
The overall requirements for training in CMR are summa-
rized in Table 3.
Summary of Requirements for Each Level of CMR Training
Table 3 Summary of Requirements for Each Level of CMR Training
Level
Duration of Training
(Months) Number of Cases
1 1 25 mentored interpretations (by a Level 2– or Level 3–trained physician)
2 3 to 6* 150 mentored interpretations (by a certified Level 2– or Level 3– [preferred] qualified CMR physician, including at least
50 as primary interpreter (and operator, if possible)†
3 At least 12 of
training*
300 mentored interpretations by a Level 3–qualified CMR physician including 100 as primary interpreter (and operator,
if possible)†
*This time represents the number of months spent reviewing cases, and interpreting, performing, and learning about cardiovascular magnetic resonance (CMR), and need not be a consecutive block of time,
but at least 50% of the time should represent mentored laboratory experience. †The case recommendations may include studies from an established teaching file, previous CMR cases, journals and/or
textbook, or electronic/on-line courses/continuing medical education. No less than 50% of the cases should be from those performed at the mentoring CMR laboratory.
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